The association between COVID-19 vaccination and idiopathic sudden sensorineural hearing loss, clinical manifestation and outcomes

Abstract

Purpose Previous data demonstrated an increased incidence of Idiopathic Sensorineural Hearing Loss (ISSNHL) in 2021 compared to 2019-2020, suggesting an association with the anti-COVID-19 vaccine. We aimed to assess our center's incidence and compare the clinical manifestations and outcomes of vaccinated vs. unvaccinated patients. Methods A retrospective chart review of all patients diagnosed with ISSNHL during 2021 was conducted and compared to patients who presented in 2018-2020. Patient demographics, audiometry features, vaccination status, and prognosis were evaluated.

COVID-19 vaccination and idiopathic sudden sensorineural hearing loss: comment

“…Fisher et al discovered that the incidence of ISS-NHL in 2021 increased significantly at our medical center, with 25% of cases occurring within 1 month of receiving anti-COVID-19 vaccination [1]. According to Fisher et al, there was no discernible difference between patients who had received vaccinations and those who had not in terms of clinical symptoms and outcomes [1]. Fisher et al came to the conclusion that more research was required, since, despite the possibility of finding other explanations, an association could not be ruled out [1].…”

“…We would like to share ideas on the publication "The association between COVID-19 vaccination and idiopathic sudden sensorineural hearing loss, clinical manifestation and outcomes [1]." Fisher et al compared the clinical symptoms and outcomes of patients who had received vaccinations vs. those who had not [1] to evaluate the incidence at their center.…”

“…We would like to share ideas on the publication "The association between COVID-19 vaccination and idiopathic sudden sensorineural hearing loss, clinical manifestation and outcomes [1]." Fisher et al compared the clinical symptoms and outcomes of patients who had received vaccinations vs. those who had not [1] to evaluate the incidence at their center. Fisher et al discovered that the incidence of ISS-NHL in 2021 increased significantly at our medical center, with 25% of cases occurring within 1 month of receiving anti-COVID-19 vaccination [1].…”

“…Fisher et al compared the clinical symptoms and outcomes of patients who had received vaccinations vs. those who had not [1] to evaluate the incidence at their center. Fisher et al discovered that the incidence of ISS-NHL in 2021 increased significantly at our medical center, with 25% of cases occurring within 1 month of receiving anti-COVID-19 vaccination [1]. According to Fisher et al, there was no discernible difference between patients who had received vaccinations and those who had not in terms of clinical symptoms and outcomes [1].…”

“…According to Fisher et al, there was no discernible difference between patients who had received vaccinations and those who had not in terms of clinical symptoms and outcomes [1]. Fisher et al came to the conclusion that more research was required, since, despite the possibility of finding other explanations, an association could not be ruled out [1].…”